JP2016501013A5 - - Google Patents

Download PDF

Info

Publication number
JP2016501013A5
JP2016501013A5 JP2015541144A JP2015541144A JP2016501013A5 JP 2016501013 A5 JP2016501013 A5 JP 2016501013A5 JP 2015541144 A JP2015541144 A JP 2015541144A JP 2015541144 A JP2015541144 A JP 2015541144A JP 2016501013 A5 JP2016501013 A5 JP 2016501013A5
Authority
JP
Japan
Prior art keywords
cell
vitro
cell activator
γδt
activator
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015541144A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016501013A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2013/073328 external-priority patent/WO2014072446A1/en
Publication of JP2016501013A publication Critical patent/JP2016501013A/ja
Publication of JP2016501013A5 publication Critical patent/JP2016501013A5/ja
Pending legal-status Critical Current

Links

JP2015541144A 2012-11-08 2013-11-08 γδＴ細胞の無ＩＬ−２増殖を誘導するための方法 Pending JP2016501013A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12306385.1 2012-11-08
EP12306385 2012-11-08
PCT/EP2013/073328 WO2014072446A1 (en) 2012-11-08 2013-11-08 Method for inducing il-2-free proliferation of gamma delta t cells

Publications (2)

Publication Number Publication Date
JP2016501013A JP2016501013A (ja) 2016-01-18
JP2016501013A5 true JP2016501013A5 (enExample) 2016-12-28

Family

ID=47189860

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015541144A Pending JP2016501013A (ja) 2012-11-08 2013-11-08 γδＴ細胞の無ＩＬ−２増殖を誘導するための方法

Country Status (4)

Country Link
US (1) US20150259645A1 (enExample)
EP (1) EP2916858A1 (enExample)
JP (1) JP2016501013A (enExample)
WO (1) WO2014072446A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107109494B (zh) 2014-11-10 2023-10-27 豪夫迈·罗氏有限公司 Il-33介导型疾病的治疗方法和诊断方法
AU2015346460A1 (en) 2014-11-10 2017-03-23 Genentech, Inc. Anti-interleukin-33 antibodies and uses thereof
IL252131B2 (en) 2014-11-17 2023-04-01 Adicet Bio Inc Transgenic gamma delta T cells
WO2016090250A1 (en) * 2014-12-04 2016-06-09 The University Of North Carolina At Chapel Hill Compositions and methods for preventing and treating graft versus host disease
MX2018013864A (es) 2016-05-12 2019-06-10 Adicet Bio Inc Métodos para la expansión selectiva de poblaciones de células t gama y composicicones de estas.
WO2018022575A1 (en) * 2016-07-26 2018-02-01 University Of Virginia Patent Foundation Compositions and methods for treating clostridium difficile infection
CN108310367A (zh) * 2017-01-18 2018-07-24 复旦大学 白介素33（il-33）在制备抗乙型肝炎病毒制剂中的用途
CA3063807A1 (en) * 2017-05-18 2018-11-22 Umc Utrecht Holding B.V. Compositions and methods for cell targeting therapies
MX2020005005A (es) 2017-11-15 2020-08-27 Adicet Bio Inc Métodos para la expansión selectiva de poblaciones de células t gamma delta delta 3 y composiciones de estas.
DE102017127984B4 (de) 2017-11-27 2019-12-05 Immatics US, Inc. Verfahren für die Vermehrung und Aktivierung von γδ-T-Zellen
KR20210069665A (ko) * 2018-09-27 2021-06-11 포스포감, 인크. 동종이계 감마/델타-t 세포의 확장 및 사용을 위한 방법 및 조성물
CN109517793B (zh) * 2018-11-30 2022-05-10 广州长峰生物技术有限公司 一种NK细胞和γδT细胞共培养的建立方法
CA3126896A1 (en) * 2018-12-03 2020-06-11 Adicet Bio Inc. Methods for selective in vivo expansion of .gamma. .delta. t-cell populations and compositions thereof
JP7767298B2 (ja) 2020-03-13 2025-11-11 ジェネンテック， インコーポレイテッド 抗インターロイキン－３３抗体及びその使用
WO2023081802A2 (en) * 2021-11-04 2023-05-11 Memorial Sloan Kettering Cancer Center Il33 proteins and methods of use thereof
WO2023132926A2 (en) * 2022-01-04 2023-07-13 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Compositions and methods for treating cancer
WO2023176896A1 (ja) * 2022-03-18 2023-09-21 国立大学法人長崎大学 糸状菌感染症の治療薬及び糸状菌感染症の治療方法
WO2026096743A1 (en) 2024-10-30 2026-05-07 Immatics US, Inc. Methods for gamma delta t cells manufacturing

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2782721B1 (fr) * 1998-09-01 2000-11-03 Inst Nat Sante Rech Med Nouveaux composes phosphohalohydrines, procede de fabrication et applications
ATE441420T1 (de) * 2002-12-02 2009-09-15 Innate Pharma Interleukin-2 und gamma delta t zellaktivator enthaltende zusammensetzungen und deren verwendungen
EP1720567A2 (en) * 2004-02-10 2006-11-15 Innate Pharma Composition and method for the treatment of carcinoma
ITRM20070437A1 (it) * 2007-08-10 2009-02-11 Istituto Naz Per Le Malattie I Metodo per la generazione ed espansione di cellule t gamma/delta regolatorie cellule cosi' ottenute e loro impieghi
JP2010004853A (ja) * 2008-06-30 2010-01-14 Japan Health Science Foundation 制御性ｔ細胞の製造方法

Similar Documents

Publication Publication Date Title
JP2017524031A5 (enExample)
WO2014153115A3 (en) Compositions and methods for reprogramming hematopoietic stem cell lineages
HK1203489A1 (en) Purinone compounds as kinase inhibitors
EA201290131A1 (ru) Производные пурина или деазапурина для применения при лечении вирусных инфекций и других заболеваний
JP2018512047A5 (enExample)
WO2015031771A3 (en) Administration of kynurenine depleting enzymes for tumor therapy
WO2015048689A8 (en) Inhibitors of bruton's tyrosine kinase
BR112014018524A2 (pt) derivados de pirimido [4,5-b]indol e métodos de utilização dos mesmos na expansão de células-tronco hematopoiéticas, composição farmacêutica e kits
MX2009006786A (es) Composiciones y metodos para el tratamiento de infecciones y tumores.
NZ609201A (en) Means and methods for treating dlbcl
WO2015035136A3 (en) Delivery system for functional nucleases
WO2018005521A3 (en) Cell culture chambers and methods of use thereof
PH12015501067A1 (en) Pyrrolopyrimidine compounds as kinase inhibitors
MD20140035A2 (ro) Metodă de tratament al hepatitei virale C
CL2013000018A1 (es) Compuestos derivados de indolizina , su procedimiento de preparacion; composicion farmaceutica; y uso en el tratamiento del cancer, entre otros.
EP2743266A4 (en) PROTEIN KINASE INHIBITORS (VARIANTS), THEIR USE FOR THE TREATMENT OF ONCOLOGICAL DISEASES AND PHARMACEUTICAL COMPOSITION BASED THEREFROM
NZ609460A (en) Method for activating helper t cell
EP3826624A4 (en) USE OF ANTI-CD2 ANTIBODY (ADC) DRUG CONJUGATE IN ALLOGENIC CELL THERAPY
MX381271B (es) Formulaciones mucoadhesivas en gel de alta dosificación de metronidazol de base acuosa y su uso para tratar la vaginosis bacteriana
CL2020001358A1 (es) Cepa vacunal de brucella modificada para el tratamiento de brucelosis
EA201690005A1 (ru) Состав с модифицированной кинетикой высвобождения
BR112013033544A2 (pt) dosagem e administração de anticorpos anti-erbb3 em combinação com paclitaxel para tratamento de cânceres ginecológicos
HUE065746T2 (hu) Készítmények és eljárások aktív mycobacterium tuberculosis fertõzés kezelésére
IL222343B (en) Compositions comprising allogeneic th1 cells and inf-gamma for treating cancer or infectious diseases
EA032977B1 (ru) Генетически стабильный онколитический рнк вирус, способ его производства и применения